Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 12.4% in 2022

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 2.3 billion yuan in 2022, down 12.4% year-on-year.

Meanwhile, the company posted 140.4 billion yuan in revenue, up 14.7% year-on-year.

At the end of the reporting period, it had 92.3 billion yuan in total assets and 63.6 billion yuan in total liabilities, with a liability-to-asset ratio of 68.9%.